Cargando…
Immune response in COVID-19: what is next?
The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current lite...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110941/ https://www.ncbi.nlm.nih.gov/pubmed/35581387 http://dx.doi.org/10.1038/s41418-022-01015-x |
_version_ | 1784709215890178048 |
---|---|
author | Li, Qing Wang, Ying Sun, Qiang Knopf, Jasmin Herrmann, Martin Lin, Liangyu Jiang, Jingting Shao, Changshun Li, Peishan He, Xiaozhou Hua, Fei Niu, Zubiao Ma, Chaobing Zhu, Yichao Ippolito, Giuseppe Piacentini, Mauro Estaquier, Jerome Melino, Sonia Weiss, Felix Daniel Andreano, Emanuele Latz, Eicke Schultze, Joachim L. Rappuoli, Rino Mantovani, Alberto Mak, Tak Wah Melino, Gerry Shi, Yufang |
author_facet | Li, Qing Wang, Ying Sun, Qiang Knopf, Jasmin Herrmann, Martin Lin, Liangyu Jiang, Jingting Shao, Changshun Li, Peishan He, Xiaozhou Hua, Fei Niu, Zubiao Ma, Chaobing Zhu, Yichao Ippolito, Giuseppe Piacentini, Mauro Estaquier, Jerome Melino, Sonia Weiss, Felix Daniel Andreano, Emanuele Latz, Eicke Schultze, Joachim L. Rappuoli, Rino Mantovani, Alberto Mak, Tak Wah Melino, Gerry Shi, Yufang |
author_sort | Li, Qing |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future. [Image: see text] |
format | Online Article Text |
id | pubmed-9110941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-91109412022-05-17 Immune response in COVID-19: what is next? Li, Qing Wang, Ying Sun, Qiang Knopf, Jasmin Herrmann, Martin Lin, Liangyu Jiang, Jingting Shao, Changshun Li, Peishan He, Xiaozhou Hua, Fei Niu, Zubiao Ma, Chaobing Zhu, Yichao Ippolito, Giuseppe Piacentini, Mauro Estaquier, Jerome Melino, Sonia Weiss, Felix Daniel Andreano, Emanuele Latz, Eicke Schultze, Joachim L. Rappuoli, Rino Mantovani, Alberto Mak, Tak Wah Melino, Gerry Shi, Yufang Cell Death Differ Review Article The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future. [Image: see text] Nature Publishing Group UK 2022-05-17 2022-06 /pmc/articles/PMC9110941/ /pubmed/35581387 http://dx.doi.org/10.1038/s41418-022-01015-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Article Li, Qing Wang, Ying Sun, Qiang Knopf, Jasmin Herrmann, Martin Lin, Liangyu Jiang, Jingting Shao, Changshun Li, Peishan He, Xiaozhou Hua, Fei Niu, Zubiao Ma, Chaobing Zhu, Yichao Ippolito, Giuseppe Piacentini, Mauro Estaquier, Jerome Melino, Sonia Weiss, Felix Daniel Andreano, Emanuele Latz, Eicke Schultze, Joachim L. Rappuoli, Rino Mantovani, Alberto Mak, Tak Wah Melino, Gerry Shi, Yufang Immune response in COVID-19: what is next? |
title | Immune response in COVID-19: what is next? |
title_full | Immune response in COVID-19: what is next? |
title_fullStr | Immune response in COVID-19: what is next? |
title_full_unstemmed | Immune response in COVID-19: what is next? |
title_short | Immune response in COVID-19: what is next? |
title_sort | immune response in covid-19: what is next? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110941/ https://www.ncbi.nlm.nih.gov/pubmed/35581387 http://dx.doi.org/10.1038/s41418-022-01015-x |
work_keys_str_mv | AT liqing immuneresponseincovid19whatisnext AT wangying immuneresponseincovid19whatisnext AT sunqiang immuneresponseincovid19whatisnext AT knopfjasmin immuneresponseincovid19whatisnext AT herrmannmartin immuneresponseincovid19whatisnext AT linliangyu immuneresponseincovid19whatisnext AT jiangjingting immuneresponseincovid19whatisnext AT shaochangshun immuneresponseincovid19whatisnext AT lipeishan immuneresponseincovid19whatisnext AT hexiaozhou immuneresponseincovid19whatisnext AT huafei immuneresponseincovid19whatisnext AT niuzubiao immuneresponseincovid19whatisnext AT machaobing immuneresponseincovid19whatisnext AT zhuyichao immuneresponseincovid19whatisnext AT ippolitogiuseppe immuneresponseincovid19whatisnext AT piacentinimauro immuneresponseincovid19whatisnext AT estaquierjerome immuneresponseincovid19whatisnext AT melinosonia immuneresponseincovid19whatisnext AT weissfelixdaniel immuneresponseincovid19whatisnext AT andreanoemanuele immuneresponseincovid19whatisnext AT latzeicke immuneresponseincovid19whatisnext AT schultzejoachiml immuneresponseincovid19whatisnext AT rappuolirino immuneresponseincovid19whatisnext AT mantovanialberto immuneresponseincovid19whatisnext AT maktakwah immuneresponseincovid19whatisnext AT melinogerry immuneresponseincovid19whatisnext AT shiyufang immuneresponseincovid19whatisnext |